{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:01:02Z","timestamp":1784030462771,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.clinthera.2020.12.004","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T03:36:37Z","timestamp":1610336197000},"page":"336-348.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study"],"prefix":"10.1016","volume":"43","author":[{"given":"Dina","family":"Abushanab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallivalappila Abdul","family":"Rouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moza","family":"Al Hail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0836-3696","authenticated-orcid":false,"given":"Brijroy","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Parappil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessam","family":"Elkassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaher","family":"Al-Shaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-954X","authenticated-orcid":false,"given":"Daoud","family":"Al-Badriyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2020.12.004_bib1","doi-asserted-by":"crossref","first-page":"e1256","DOI":"10.1542\/peds.2008-1780","article-title":"Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus","volume":"122","author":"Cherif","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2020.12.004_bib2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1747-0803.2012.00668.x","article-title":"Comparison of oral and intravenous ibuprofen for medical closure of patent ductus arteriosus: which one is better?","volume":"7","author":"Olukman","year":"2012","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.clinthera.2020.12.004_bib3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1542\/peds.2009-3506","article-title":"Patent ductus arteriosus of the preterm infant","volume":"125","author":"Hamrick","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2020.12.004_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12887-018-1215-7","article-title":"Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)","volume":"4","author":"Hundscheid","year":"2018","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.clinthera.2020.12.004_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/pch\/15.5.267","article-title":"Patent ductus arteriosus in premature infants: a never-closing act","volume":"15","author":"Th\u00e9baud","year":"2010","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.clinthera.2020.12.004_bib6","first-page":"314","article-title":"Comparison of two dose regimens of ibuprofen for the closure of patent ductus arteriosus in preterm newborns","volume":"92","author":"Dornelles","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clinthera.2020.12.004_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13063-016-1294-4","article-title":"Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial","volume":"17","author":"Dani","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.clinthera.2020.12.004_bib8","first-page":"CD003481","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants","volume":"4","author":"Ohlsson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2020.12.004_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpedsurg.2006.09.040","article-title":"Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost?","volume":"42","author":"Raval","year":"2007","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.clinthera.2020.12.004_bib10","doi-asserted-by":"crossref","first-page":"F279","DOI":"10.1136\/archdischild-2011-300532","article-title":"Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants","volume":"97","author":"Erdeve","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.clinthera.2020.12.004_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jpeds.2010.10.008","article-title":"Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus","volume":"158","author":"Gokmen","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clinthera.2020.12.004_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1542\/peds.2009-0003","article-title":"Oral versus intravenous ibuprofen: which is better in closure of patent ductus arteriosus?","volume":"123","author":"Erdeve","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2020.12.004_bib13","first-page":"56","article-title":"Enteral ibuprofen versus indomethacin in the treatment of PDA in preterm newborn infants","volume":"44","author":"Akisu","year":"2001","journal-title":"Turk Pediatr J"},{"key":"10.1016\/j.clinthera.2020.12.004_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4274\/tpa.45.329","article-title":"The efficacy of oral ibuprofen in the treatment of clinically significant patent ductus arteriosus in preterm infants","volume":"45","author":"Arslan","year":"2010","journal-title":"Turk Arch Pediatr"},{"key":"10.1016\/j.clinthera.2020.12.004_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2007-976550","article-title":"Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study","volume":"24","author":"Aly","year":"2007","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.clinthera.2020.12.004_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-981853","article-title":"Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants","volume":"24","author":"Cherif","year":"2007","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.clinthera.2020.12.004_bib17","first-page":"99","article-title":"Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates","volume":"39","author":"Hairprasad","year":"2002","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.clinthera.2020.12.004_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1542\/peds.112.5.e354","article-title":"Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study","volume":"112","author":"Heyman","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2020.12.004_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14767050903198314","article-title":"Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns","volume":"22","author":"Guimaraes","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.clinthera.2020.12.004_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1017\/S1047951116000822","article-title":"Does ibuprofen treatment in patent ductus arteriosus alter oxygen free radicals in premature infants?","volume":"27","author":"Akar","year":"2017","journal-title":"Cardiol Young"},{"key":"10.1016\/j.clinthera.2020.12.004_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000445101","article-title":"A\u00a0hemodynamically significant patent ductus arteriosus does not affect cerebral or renal tissue oxygenation in preterm infants","volume":"110","author":"Van der Laan","year":"2016","journal-title":"Neonatology"},{"key":"10.1016\/j.clinthera.2020.12.004_bib22","first-page":"21","article-title":"What is a hemodynamically significant PDA in preterm infants?","volume":"14","author":"Shepherd","year":"2019","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.clinthera.2020.12.004_bib23","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3730","article-title":"Patent ductus arteriosus in preterm infants","volume":"137","author":"Benitz","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2020.12.004_bib24","series-title":"Pediatric Drug Information","year":"2020"},{"key":"10.1016\/j.clinthera.2020.12.004_bib25","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1542\/neo.6-8-e369","article-title":"Acute renal failure management in the neonate","volume":"6","author":"Chua","year":"2005","journal-title":"NeoReviews"},{"key":"10.1016\/j.clinthera.2020.12.004_bib26","series-title":"Newborn","year":"2017"},{"key":"10.1016\/j.clinthera.2020.12.004_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12955\/emhpj.v6i0.388","article-title":"Oral versus intravenous ibuprofen for the early closure of patent ductus arteriosus in low birth weight preterm infants","volume":"6","author":"Hoxha","year":"2013","journal-title":"Eur Med Health Pharm J"},{"key":"10.1016\/j.clinthera.2020.12.004_bib28","series-title":"Decision Modeling for Health Economics Evaluation","year":"2006"},{"key":"10.1016\/j.clinthera.2020.12.004_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/adc.2003.027698","article-title":"Severity of the ductal shunt: a comparison of different markers","volume":"90","author":"El Hajjar","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.clinthera.2020.12.004_bib30","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1542\/peds.2008-2232","article-title":"A\u00a0second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants","volume":"124","author":"Richards","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2020.12.004_bib31","doi-asserted-by":"crossref","first-page":"1673e7","DOI":"10.1007\/s00431-012-1805-6","article-title":"Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus","volume":"171","author":"Van der Lugt","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clinthera.2020.12.004_bib32","series-title":"Patent Ductus Arteriosus (PDA):medical Treatment and Indications for Surgical Closure","year":"2020"},{"key":"10.1016\/j.clinthera.2020.12.004_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.jp.7200296","article-title":"Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia: a pilot study","volume":"20","author":"Raju","year":"2000","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.clinthera.2020.12.004_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/0091270003254635","article-title":"Pharmacokinetics of oral ibuprofen in premature infants","volume":"43","author":"Sharma","year":"2003","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2020.12.004_bib35","unstructured":"Sample size calculation in economic evaluation. Cancer research economics support team [Internet]. [Last accessed 2020 April 18]. Available from: http:\/\/www.crest.uts.edu.au\/Apdfs\/Factsheet-Sample_Size_in_EE-FINAL.pdf."},{"key":"10.1016\/j.clinthera.2020.12.004_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12874-018-0571-1","article-title":"A\u00a0new approach for sample size calculation in cost-effectiveness studies based on value of information","volume":"18","author":"Bader","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clinthera.2020.12.004_bib37","first-page":"S64","article-title":"Sample size calculation in trials of public health interventions: a discussion of implications for health economists","volume":"382","author":"Lloyd-Williams","year":"2013"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182030552X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182030552X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:54:46Z","timestamp":1758963286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929182030552X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S014929182030552X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.12.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}